A Home Built of Courage and Chlorhexidine

Harsh’s illness began with a cough and a chill that burrowed into his bones. A hazy patch on the X-ray revealed pneumonia, and the plan sounded simple: IV antibiotics, oxygen, fluids. 

“Every pill felt like a promise, but the fever kept laughing at us.”

On 3^rd day, he was in the ICU. The team moved stepwise through therapy – first-line antibiotics, then second-line combinations of antibiotics, and finally last-resort antibiotics that were not only expensive but also toxic. Blood cultures returned with words that closed the air in the room: resistant to usual antibiotics; resistant to broader combinations.

His breathing grew heavier, blood pressure dipped, and ventilatory support kept him afloat. Days turned into tallies -day 7 of fever, day 10 of oxygen masks, day 13 and then day 20 of antibiotics that failed in journals and were failing in him. The family faced decisions no one wants to make: intubate again or not, resuscitate or allow a natural end.

“He said, ‘Take me home,’ and we stood frozen. Every choice felt like betrayal – hope on one side, his wish on the other.”

In that instant, the hospital walls felt heavier than hope, and the family realized care was no longer about medicine alone—it was about dignity and the family’s world shifted from hospital corridors to the fragile hope of home care.  Love built a hospital room at home -rails on the bed, oxygen cylinders, suction, sterile dressing kits, and nurses on every shift. Medicines arrived in brown bags; lab reports spoke in arrows and forecasts of storm after storm. Savings thinned to bone and yet hope endured.

“I’m not afraid. I’m tired. Let me go” –  Harsh, to his family one night as monitors traced his heartbeats like a small bird.

Two months passed like a long winter with no gap in the cloud. One night, numbers softened and slid away. Later, Meera, his wife, paused over a lab report and the term that had shadowed them: multidrug resistant. ‘These words didn’t exist when we were children,’ she told her daughter. ‘Now they follow us everywhere.’ 

From a Family Member: “We thought antibiotics were magic. No one told us they could fail.”

Another Family’s Loss

A tearful daughter laments, “the diagnosis of cancer was daunting for us, but the reassurance from the doctor that it is curable gave us hope. My mother was admitted for her first chemotherapy, but suddenly her condition worsened. The doctor informed them that she had acquired an infection and reassured us that she has been started on antibiotics and would soon recover. However, days turned to weeks, but the fever failed to abate. The hospital tried all possible antibiotics, but the superbug won; and we lost her not to cancer but to a bug! We never imagined a tiny germ could defeat every medicine the doctors had.

“We kept asking, isn’t there one more antibiotic? But the answer was silence.”

Another story: The Battle That Almost Broke Us

Ravi was admitted with a raging infection that spiraled out of control. Doctors escalated from first-line antibiotics to last-resort drugs. His blood pressure dipped; breathing faltered; consent forms piled up.

After weeks of ventilators and toxic medications, the fever finally broke and the tubes came out. He returned home but the question that haunts his family remains: what if those medicines hadn’t worked?

From a Caregiver:

“Watching the monitors dip while waiting for an antibiotic to work is a kind of helplessness you can’t describe.”

From a Survivor:

“I walked out of the ICU, but the fear stayed – what if next time, there’s nothing left to try?”

AMR: A Quiet Emergency in Every Home

This is the landscape of antimicrobial resistance (AMR): where therapies we rely on no longer work and the distance between infection and cure keeps widening.

AMR does not spread like a virus, but grows in every ward, every prescription, and every community. First-line treatments fail; second-line options buckle; even last-resort medications offer only brief, deceptive pauses before fever rises again.

AMR: A Natural Phenomenon Accelerated by Human Actions

AMR begins as a natural biological process – microbes adapt to survive. Bacteria have always evolved defence mechanisms against threats, including antibiotics. However, this phenomenon is accelerated by human behaviour, especially the overuse and misuse of antibiotics.

Unlike most medicines, antibiotics are unique: their impact is not confined to the individual taking them. Every unnecessary dose or incomplete course creates selective pressure, enabling resistant bacteria to thrive and spread. This means one person’s misuse can affect an entire community, turning what should be a personal treatment into a public health challenge.

The causes are embedded in our practices: antibiotics taken without prescriptions, courses stopped midway to save money, overcrowded hospitals where bacteria trade survival tactics, and environmental contamination from pharmaceutical waste.

The Fragile Lifeline: Why We Rely on Last-Resort Drugs

Compounding the crisis, the pipeline for new antibiotics is running dry. Development of new antibiotics is slow, expensive, and often unprofitable, leaving us with last-resort antibiotics that cost more than a month’s salary and sometimes even more and offer only temporary reprieve.  Until now, new antibiotics have managed to keep pace with evolving resistance, but in the future, we may not have that safety net as the pipeline continues to shrink. This makes it critical to preserve the precious resources we have today – losing antibiotics would mean gambling on the hope that future science will rescue us from infections that could otherwise be prevented or treated now.

Solutions Are Within Reach

Prevention and stewardship cost far less than escalation and failure. Hand hygiene, rational prescribing, and informed conversations can change the course of care. Stewardship must become a culture, not just a protocol.

Together, these steps form a safety net – one that protects not just individual patients but entire health systems from the silent pandemic of antimicrobial resistance.

A Bell That Rings for Change

Harsh’s bell still hangs above the television. Once, it marked victory over cancer; now it calls for accountability and hope. His story deserves more than sorrow – it deserves a promise that the next family will not watch antibiotics fail, one after another.

Meera volunteers with a patient group, urging families to preserve the power of life-saving antibiotics avoid self-medication, sharing of drugs, and demanding antibiotics unnecessarily. Let the next bell ring for recovery, not remembrance.

The post The Fever That Wouldn’t Break: When antibiotics fail, hope becomes the last medicine appeared first on InnoHEALTH magazine.

Rising Temperatures and Health Risks

One of the most alarming effects of climate change is the increasing frequency and intensity of heatwaves. In recent years, cities like Delhi have witnessed soaring temperatures reaching up to 50 degrees Celsius. This rise in temperature disproportionately affects vulnerable populations, including infants, the elderly, and pregnant women. Heat-related illnesses, such as heat strokes, heat exhaustion, and dehydration, have become more prevalent, contributing to increased morbidity and mortality rates. Additionally, extreme heat can exacerbate pre-existing health conditions like cardiovascular and respiratory diseases.

Several factors contribute to this extreme heat, including rapid urbanization and the proliferation of concrete structures. The loss of natural water bodies and green spaces exacerbates urban heat island effects, making cities significantly warmer than their rural counterparts. To combat this, urban planning must prioritize the preservation of lakes, ponds, and green corridors while implementing solutions such as reflective rooftops, green roofs, and solar panel integration to minimize heat absorption. Furthermore, the implementation of early warning systems for heatwaves, coupled with public awareness campaigns on heat safety, can significantly reduce heat-related health risks.

The Impact of Poor Urban Planning on Flooding

Dr. Bhattacharya emphasized that poor urban planning has led to increased incidents of urban flooding in cities like Chennai and Kerala. Illegal constructions, deforestation, and unplanned settlements have disrupted natural drainage systems, resulting in recurrent floods that displace thousands and damage infrastructure. These floods not only cause immediate health risks like drowning and injuries but also lead to long-term health consequences due to waterborne diseases, displacement, and mental health issues.

While relocating established communities is challenging, measures such as improved drainage systems, afforestation, and the incorporation of sustainable urban design can help mitigate the risks. Learning from ancient civilizations like the Indus Valley, which had efficient water management systems, can inform modern strategies to address urban flooding. Additionally, the implementation of green infrastructure solutions like rain gardens and permeable pavements can help absorb excess rainwater and reduce flood risks.

Biodiversity Loss and Climate Change

The loss of biodiversity is another significant consequence of climate change. The introduction of non-native species, such as water hyacinths, has disrupted local ecosystems by depleting oxygen levels in water bodies, leading to the decline of aquatic life and affecting the availability of fish as a food source. Similarly, species like eucalyptus and avocado trees, though beneficial in some aspects, have exacerbated water scarcity due to their high water consumption, impacting agriculture and human health.

Dr. Bhattacharya suggested focusing on native plant species and sustainable agricultural practices to restore ecological balance. She cited examples of innovative solutions such as phytoremediation using duckweed, which naturally purifies contaminated water bodies while supporting biodiversity. Additionally, the conservation of forests and wetlands, along with the promotion of agroforestry, can play a vital role in preserving biodiversity and mitigating climate change impacts.

Antibiotic Resistance and Emerging Contaminants

One of the more alarming discussions revolved around the growing threat of antimicrobial resistance (AMR). The excessive use of antibiotics in human medicine, veterinary medicine, and agriculture, coupled with improper disposal practices, has led to the contamination of water bodies, soil, and even the air, fostering the emergence and spread of drug-resistant bacteria. The presence of pharmaceutical waste and other emerging contaminants like microplastics and endocrine disruptors in untreated water supplies further exacerbates this issue, posing a significant risk to human and environmental health.

To address AMR, hospitals must implement dedicated wastewater treatment systems to prevent untreated medical waste from entering the environment. Additionally, advancements in bioreactors and natural water filtration techniques using plant-based solutions offer promising approaches to tackling this challenge. Furthermore, stricter regulations on antibiotic use and disposal, along with the development of new antibiotics and alternative therapies, are crucial in combating AMR.

Innovative Climate Solutions and the Role of Policy

Several green innovations, such as biodegradable plastics, algae-based fuels, biofuels, biofertilizers, renewable energy technologies, and carbon capture and storage, have the potential to mitigate climate change impacts. However, their widespread adoption remains limited due to high costs, lack of awareness, policy inertia, and vested interests in fossil fuels.

Government intervention plays a crucial role in promoting sustainable alternatives. Stricter regulations on plastic use, incentives for renewable energy adoption, carbon pricing mechanisms, and improved monitoring of industrial waste disposal can accelerate the transition to a greener future. Public awareness campaigns, community-driven conservation efforts, and international collaboration also hold immense potential in fostering sustainable practices and addressing the global challenge of climate change.

Conclusion

Climate change is not merely an environmental issue—it is a public health crisis that demands immediate and collective action. By integrating sustainable urban planning, promoting biodiversity conservation, addressing antimicrobial resistance, and embracing innovative climate solutions, we can turn the tide against the adverse effects of climate change on health and healthcare.

The insights shared by Dr. Bhattacharya underscore the urgency of interdisciplinary collaboration in tackling climate-related health challenges. As individuals, communities, and policymakers, it is imperative that we work together to build a healthier, more sustainable future for generations to come. This requires a paradigm shift towards a more holistic and preventive approach to health, recognizing the interconnectedness of human health and the environment. Only by working together can we safeguard our planet and ensure a healthy future for all.

Composed by:

InnoHEALTH magazine digital team

The post Turning the Tide: Proactive Solutions for Climate Change and Health appeared first on InnoHEALTH magazine.

With the theme “Tackling Antimicrobial Resistance: A Multi-Disciplinary Approach” unfurled the beginning of the 18^th IC InnovatorClub meeting held on May 25,2024.

The event brought together leading experts, policymakers, and healthcare professionals to discuss innovative solutions to one of the most pressing public health challenges of our time. Antimicrobial resistance (AMR) poses a significant threat to global health, demanding a concerted effort across various sectors to combat its spread effectively.

Introduction and setting the tone

In his opening remarks, Mr. Sachin Gaur set  the tone of urgency and immediate collaboration as he addressed the critical issue of antimicrobial resistance (AMR). Drawing from personal experience and insights gained from international forums, he underscored the global nature of the problem and emphasised on the need for proactive strategies in combating AMR. Mr.Gaur acknowledged the growing awareness surrounding AMR but calls for a shift from reactionary approaches to more comprehensive and coordinated efforts. 

Keynote Address by Ms. Jasmine Kaur

In her keynote address, Jasmine Kaur, a researcher at the division of biomedical informatics at ICMR and a Ph.D. candidate at the Department of Computational Biology at IIIT Delhi, delves into the challenges of antimicrobial resistance (AMR) and suggested innovative solutions through a multidisciplinary lens. She elucidated the essence of AMR, highlighting its detrimental impact on global health by rendering previously effective medications ineffective. Kaur emphasised the urgent need for proactive strategies in combating AMR, citing alarming statistics of associated deaths in 2019. She identified the key challenges hindering effective AMR management, such as fragmented datasets, lack of accessible technical innovations, and implementation gaps. Providing insights into India’s AMR surveillance landscape. Ms.Kaur discussed various national-level surveillance systems and enlightened the importance of standardising data collection and enhancing data sharing mechanisms. She advocated for the development of an ideal AMR surveillance system that is interoperable, standardised, and capable of providing nationwide projections. Ms.Kaur introduced tools developed by ICMR for data collection and highlights their significance in guiding antimicrobial use policies. Drawing from her recent study published in Lancet Southeast Asia, she showcased the utility of AI-based insights in analysing AMR trends and identifying indicator antibiotics.She concluded by stressing the importance of collaborative efforts among stakeholders in combating AMR and called for greater implementation and awareness to make substantial progress in this global health challenge.

Keynote Address by Advocate Rabin Majumdar

In the keynote address, Advocate Rabin Majumdar, an advocate at the Supreme Court of India focused on AMR and environmental law, highlights the legal dimensions of antimicrobial resistance (AMR) and its implications for public health and the environment. He emphasised on the need for global cooperation in addressing AMR and stressed the importance of interstate and international coordination. Majumdar discussed India’s efforts in mapping the AMR research landscape and called for better coordination between various governmental departments. He shared his insights on the environmental impact of pharmaceutical manufacturing and augmented for smart regulation of antibiotic use to mitigate AMR. He further highlighted the role of the National Green Tribunal in addressing AMR-related environmental issues and underscores the importance of regulatory mechanisms in preventing contamination. Despite existing policies, he acknowledged implementation of challenges and stressed the need for strong legal commitment and public-private partnerships. Majumdar concluded by emphasising the importance of comprehensive and coordinated efforts in involving all stakeholders to effectively combat AMR on a global scale.

Panel Discussion

The panel discussion, moderated by Adv. Rabin Majumder, brought together esteemed experts to explore various facets of antimicrobial resistance (AMR) and proposed solutions to combat this global health challenge. Dr. Ranga Reddy Burri, President of the Infection Control Academy of India (IFCAI), emphasised the One Health approach to AMR, stressing the interconnectedness of human, animal, and environmental health. Dr. Sonal Saxena, Director Professor & Head, Microbiology Department , Maulana Azad Medical College, shed light on the challenges of AMR in hospital settings, particularly focusing on hospital-acquired infections and the importance of infection control practices. Dr. Vikash Ranjan,Manager Medical Affairs,BioMérieux, provided insights from the industry perspective, highlighting the crucial role of diagnostics in managing AMR, including the need for rapid and accurate tests to guide targeted therapy and reduce antibiotic misuse.

Throughout the discussion, several key themes emerged. Collaboration across disciplines and sectors was highlighted as essential for developing comprehensive strategies to combat AMR effectively. The importance of early diagnosis, accessible diagnostic tools, and technological advancements in diagnostics were underscored as crucial elements in managing AMR in healthcare settings. Additionally, the panellists emphasised the significance of education and public awareness in addressing AMR, advocating for curriculum development, public awareness campaigns, and community engagement initiatives to promote responsible antibiotic use.

In conclusion, the panel discussion underscored the urgent need for a holistic and coordinated approach to address AMR, involving collaboration between academia, industry, policymakers, healthcare professionals, and the public. By leveraging the strengths of each sector and implementing evidence-based strategies, there is hope for effectively managing and controlling AMR to safeguard public health and preserve antibiotic effectiveness for future generations.

The post 18th IC InnovatorCLUB Virtual Meeting Report appeared first on InnoHEALTH magazine.

1. E-pharmacy has seen significant growth in recent years. Can you share your insights on how digital health platforms are revolutionizing the way medicines are accessed and delivered to consumers?
   E-pharmacies have significantly enhanced accessibility, affordability, convenience & comfort while empowering customers with useful information to manage their healthcare better. We let customers request medicines by uploading a prescription through a convenient app/ website and have them delivered to their homes. This service is especially helpful for people who live in rural places, elderly people who have mobility problems, or need to get prescription refills on a regular basis. Also, many times medicines are not easily available in one geography, while they may be available in other locations – a digital platform manages to ensure better availability of medicines as needed by consumers. Laboratory tests and Teleconsultations are also integrated into digital health systems, further empowering patients’ access to medical consultations. These developments ensure better prescription adherence and speed up obtaining medications. Digital health platforms enhance full transparency and safety in medication delivery, given everything is end to end tracked and traced. Also, they offer detailed information on drug availability, pricing, and alternatives, allowing consumers to make informed choices. Additionally, the well organized platforms incorporate stringent verification processes and quality checks to ensure that medications are genuine and safe. By analyzing patient data, these platforms can provide dosage reminders, health tips and even managed care programs, improving overall health outcomes.
   
   
2. How do digital health platforms leverage their platform to empower users in making informed decisions about their health, accessing healthcare services, and adopting preventive healthcare measures?
   Platforms for digital health give consumers access to a multitude of information from around the world, and use that for empowering our customers with deeper knowledge. These services provide detailed information of the medicines patients are taking and many other health related information such as – symptom checks, instructional materials, and guidance from medical specialists. They let users schedule appointments, manage their health data, and get reminders for things like medicine and checkups. Users may monitor vital signs and activity levels by incorporating wearable technology, which promotes proactive health management. Educational content, including articles, videos, and webinars on various health topics, keeps users informed and engaged. Additionally, community forums and support groups allow users to share experiences, seek advice, and gain support from peers facing similar health challenges promoting preventive health.
   
   
3. Antimicrobial resistance (AMR) is a growing concern globally. How do you see digital health platforms playing a role in addressing AMR, particularly in ensuring responsible antibiotic use and promoting awareness among consumers?
   Digital health platforms play a crucial role in combating AMR. Given that every dispensation is tracked digitally end to end, it is much easier to ensure proper Antibiotic adherence through digital platforms. Ideally, all Antibiotic dispensation should be on similar platforms only, to ensure there is no self medication and prescription abuse for antibiotics. Also, the platforms play a role towards promoting responsible antibiotic use and increasing awareness in both the patients and doctors associated with their platforms. Educational content about the dangers of AMR and the importance of completing antibiotic courses is readily available to consumers. Moreover, these platforms can be leveraged to track antibiotic prescriptions and usage patterns, providing data that can be analyzed to identify and mitigate misuse trends. Digital health platforms can integrate decision support tools for healthcare professionals to aid in antibiotic prescribing. This data-driven approach aids in developing targeted interventions to curb AMR. Platforms should use their reach and influence to advocate for policy changes and investments in AMR prevention and control.
   
   
4. Artificial intelligence (AI) is increasingly being integrated into e-pharmacy platforms to enhance services and improve efficiency. Can you discuss some of the AI-driven innovations implemented to enhance user experience and optimize healthcare outcomes?
   AI enhances e-pharmacy services by improving accuracy, efficiency, and user experience. AI algorithms personalize medication recommendations based on individual health profiles and past behaviors. Chatbots powered by AI provide instant customer service, answering queries and guiding users through the purchasing and delivery process. AI-driven predictive analytics help manage inventory by forecasting demand, reducing the likelihood of stockouts or overstocking. Furthermore, AI applications in drug interaction checks ensure safe medication combinations, enhancing patient safety. We are also working upon data science models which can digitize typewritten and handwritten health records, which again can serve the ecosystem beyond just pharmacies.
   
   
5. The online sale of medicines has been subject to regulatory scrutiny in many countries, including India. What are your thoughts on potential new regulations governing the online sale of medicines, and how do you foresee these regulations impacting the e-pharma industry?
   A lot of controversy around online pharmacies in many countries pertains to cross border trade of medicines, for which many countries have regulated that online pharmacies have to be domiciled within the country only. Also, today China, Europe, Latin America, USA – all have ePharmacies thriving. Especially post covid, the need for a national digital infrastructure to access medication is well recognized. In India, presently, all dispensation is governed by the Drugs & Cosmetics Act & Rules 1945, and players fully comply with those provisions. In addition, the players need to comply with IT Act and other rules governing retail and eCommerce. However, we do feel the time has come for the country to have an integrated and updated set of rules, given that today the models are governed under multiple Acts and harmonizing them will ensure much better ease of doing business. Also, the various upcoming innovative models at play may have specific requirements. The impending new Drugs and Medical Devices Act has already mentioned online sales of medicines would be specifically addressed. We will continue our engagements with the regulators to help frame comprehensive sectoral guidelines that ensure the safe and efficient operation of e-pharmacies.
   
   
6. What steps do online platforms typically implement to prevent the sale of counterfeit medications?
   ePharmacies are fundamentally well positioned to ensure accountability in the supply chain, since all medicines are end-to-end trackable and traceable here from supplier to patient, unlike in the open market where a lot of such medicines are dispensed without a clear traceability, often involving cash transactions. Digitization of the supply chain is the largest weapon in the fight against counterfeit, and the ePharmacy model naturally has that advantage. Also, given all transactions come with an invoice, there is proper accountability of various players embedded in the system, besides better tax realization for the government. Additionally, ePharmacies implement several measures to prevent the sale of counterfeit medications. All good ePharmacies have a robust partner onboarding mechanism in place. They source products directly from reputed manufacturers and authorized distributors, which is critical towards ensuring the authenticity of stock. Advanced tracking systems and barcoding technology enable traceability from the distributor to the consumer. ePharmacies also perform regular audits and quality checks, and take consumer feedback seriously for end to end checks.
   
   
7. What are some of the key challenges facing the e-pharma industry, and how are digital health platforms addressing these challenges to ensure compliance, safety, and quality in the delivery of healthcare services?
   The key challenge for the ePharmacy industry today is around ease of doing business. All players have to comply with various laws and rules which come under various acts, and many times a single department is not aware of the other laws governing the ecosystem. For example, it is commonly seen that a local Drug Inspector is not aware of the IT Act, Consumer Protection Act or eCommerce rules, and it is a cumbersome process to respond to various issues that may come up. Also, there is a need for a level playing field, and it is well known that prescription requirements, presence of pharmacists and other regulations are often not equally imposed. As a result, a lot of customers on ePharmacy platforms are disappointed that we seek prescriptions when they easily get the same medicines without in the open market. Another challenge is around ensuring data security, and with the upcoming data privacy laws, there is a need to set up adequate systems to manage that. Digital health platforms address these challenges by investing in secure, scalable IT infrastructure and adopting comprehensive compliance protocols. They collaborate with regulatory bodies to stay updated on regulations and adapt practices accordingly. To ensure product authenticity, e-pharmacies partner with companies and their authentic vendors, leverage advanced technologies like blockchain and AI for supply chain management and verification. Continuous stakeholder engagement and user education and transparent operations build consumer trust and ensure quality service delivery. Digital health platforms prioritize data privacy and security by implementing robust encryption protocols, access controls, and data anonymization techniques to protect patient information.
   
   
8. With the rapid advancement of technology, what do you envision as the next digital revolution in the healthcare industry, and how do you see digital health platforms adapting to and driving this transformation?
   The next digital revolution in healthcare will involve the integration of advanced AI, machine learning, and the Internet of Medical Things (IoMT). These technologies will enable more precise and faster diagnostics, personalized treatment plans taking into account health data and real time wearable data, and seamless interoperability among different healthcare systems. Digital health platforms will likely evolve to offer holistic health management ecosystems, integrating fitness, nutrition, mental health, and medical care into a single user interface. This transformation will enhance preventive care, early detection of diseases, and patient engagement. 
   
   
9. Personalized medicine and telemedicine are emerging trends in healthcare. How do you see digital health platforms evolving to incorporate these trends into their service offerings, and what opportunities do they present for improving patient care?
   Personalized medicine and telemedicine may be driven faster by and also effectively integrated into digital health platforms, providing customized healthcare solutions that consider genetic, environmental, and lifestyle aspects. Genetic data will be used by platforms to offer individualized medication recommendations and health guidance. The field of telemedicine is expected to grow, offering a wide range of virtual care solutions such as digital treatments, remote monitoring, and expert consultations. Opportunities to enhance patient outcomes, lower healthcare costs, and broaden access to high-quality treatment are presented by these trends. Resultant Chronic disease management programs, virtual care solutions, remote patient monitoring and home healthcare will lead to better health outcomes. 
   
   
10. Data privacy and security are critical considerations in the digital health space. How do digital health platforms ensure the confidentiality and integrity of user data while leveraging data analytics to enhance their services?
    To ensure data privacy and security, digital health platforms implement robust cybersecurity measures, including encryption, secure data storage, and multi-factor authentication. They adhere to regulations like national data protection laws to safeguard user data. Regular security audits, employee training on data privacy, and transparent data handling practices enhance trust. 
    
    
11. Collaboration and partnerships are essential for the success of digital health platforms. Can you share some examples of successful collaborations undertaken to expand reach and enhance service offerings?
    Partnerships with academic institutions, technology businesses, pharmaceutical companies, and healthcare providers are some of the key digital health collaborations. Partnerships with pharmaceutical firms, for instance, can increase medicine availability and optimize supply chains and improve access to patient support programs. By using cutting-edge technologies like artificial intelligence, partnerships with tech companies can improve platform capabilities. Innovation in digital health solutions is being fostered through cooperative research collaborations with academic institutions. These alliances broaden their clientele, improve the services they provide, and propel the sector forward.
    
    
12. Finally, what is your vision for the future of e-pharmacy and digital health, and how do you see these platforms contributing to the advancement of healthcare delivery and accessibility?
    India today has an opportunity to create the new model of digital access to healthcare, which is not only a model for India but for the entire global south. Digital Health platforms hold the promise of making healthcare personalized, integrated, accessible and affordable – and in all these dimensions India is well endowed to lead the world in creating the new age model and technology. E-pharmacy and digital health will prosper in the future when state-of-the-art technology is combined with a patient-first mentality. E-pharmacies are now transforming into all-inclusive health management platforms that provide a variety of services, including telemedicine, diagnostics services, personalized health advice, and pharmaceutical delivery. E-pharmacy and digital health platforms have the potential to transform by delivering personalized and precision healthcare, empowering patients, promoting collaborative care models, expanding access and equity, and driving continuous innovation and collaboration across the healthcare ecosystem. By leveraging technology, data-driven insights, and collaborative partnerships, these platforms can contribute to a future where healthcare is accessible, equitable, and patient-centered, ultimately improving the health and well-being of individuals and communities. By increasing efficiency, personalization, and accessibility, digital health platforms will play an integral part in improving healthcare delivery.

The post Revolutionizing Healthcare: Insights into the Future of E-Pharmacies and Digital Health Platforms appeared first on InnoHEALTH magazine.

Water, as we all know, is the utmost need of our survival. Human body comprises around 60% water and the fact that less consumption of water leads to various diseases in the future. Apart from facts and figure, one simple question we often forget to inquire is where this water is coming from? Surface water i.e. lakes, rivers and ponds or groundwater i.e. tube wells, bore well, well as these are the two sources that give us a glass of water.

Health Organization in India: To know the near-exact extent of AMR, AMR surveillance networks were initiated by the Indian Council of Medical Research (ICMR) and the National Centre for Disease Control (NCDC) in 2013 and 2014, respectively. In 2015, these two organizations along with the support from Centers for Disease Control and Prevention (CDC) USA, started a systematic assessment of the prevailing IPC practices in India with the aim of formulating new guidelines for preventing hospital-acquired infections.

The post Post Antibiotic World appeared first on InnoHEALTH magazine.

Tanya Spisbah, Director with Australia India Institute, Delhi is a renowned and influential expert on Australia-India relations, particularly with respect to health and sustainable development. A career diplomat with the Australian Department of Foreign Affairs and Trade for more than a decade, Ms. Spisbah served from 2014-17 at the Australian High Commission in New Delhi, specializing in health and technology diplomacy for inclusive, sustainable growth. She notably led the health agenda resulting in the Australian and Indian Prime Ministers exchanging an MoU for Health and Medicine, paving the way for cooperation on digital health.

The post Addressing Unmet Needs in India's Health System appeared first on InnoHEALTH magazine.